BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6793604)

  • 1. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism.
    Tsiftsoglou AS; Mitrani AA; Housman DE
    J Cell Physiol; 1981 Sep; 108(3):327-35. PubMed ID: 6793604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells.
    Tsiftsoglou AS; Gusella JF; Volloch V; Housman DE
    Cancer Res; 1979 Oct; 39(10):3849-55. PubMed ID: 289436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
    Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
    J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic regulation of MEL cell commitment.
    Levenson R; Macara I; Cantley L; Housman D
    J Cell Biochem; 1983; 21(1):1-8. PubMed ID: 6575972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
    Tsiftsoglou AS; Sartorelli AC
    Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
    Sherman ML; Shafman TD; Kufe DW
    J Cell Physiol; 1988 Mar; 134(3):429-36. PubMed ID: 2450878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
    Durkin JP; Chakravarthy B; Tremblay R; Jouishomme H; Whitfield JF; Biquard JM; Krsmanovic V
    Cancer Res; 1992 Nov; 52(22):6329-34. PubMed ID: 1423278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS; Wong W
    Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells.
    Ardman B; DiMambro E; Levy SB; Schwartz RS
    J Immunol; 1987 Sep; 139(6):2038-43. PubMed ID: 3476672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E; Reuben RC; Rifkind RA; Marks PA
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
    Lo SC; Aft R; Mueller GC
    Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M
    J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation.
    Bridges K; Levenson R; Housman D; Cantley L
    J Cell Biol; 1981 Aug; 90(2):542-4. PubMed ID: 6793600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line.
    Francastel C; Groisman R; Pfarr CM; Robert-Lézénès J
    Oncogene; 1994 Jul; 9(7):1957-64. PubMed ID: 8208542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation.
    Ai Z; Misra S; Susa M; Varticovski L; Cohen CM
    Exp Cell Res; 1995 Aug; 219(2):454-60. PubMed ID: 7641797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
    Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin.
    Vannucchi AM; Grossi A; Paoletti F; Rafanelli D; Bacci P; Ferrini PR
    Exp Hematol; 1992 Dec; 20(11):1296-301. PubMed ID: 1493858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the cell cycle in commitment of murine erythroleukemia cells to erythroid differentiation.
    Geller R; Levenson R; Housman D
    J Cell Physiol; 1978 May; 95(2):213-22. PubMed ID: 274446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.